Cumberland Pharmaceuticals Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CPIX | AQST | COLINZ.BO | HLS.TO | DERM | 0950.HK | |
|---|---|---|---|---|---|---|
| Market cap | 66.52M | 476.94M | 173.79M | 131.47M | 133.50M | 638.89M |
| P/E (TTM) | — | — | 6.2 | — | — | 5.4 |
| Forward P/E | 31.7 | -6.7 | — | -43.2 | -78.8 | 7.8 |
| Price/book | 3.8 | -13.8 | 1.7 | 1.7 | 4.1 | 0.3 |
| Dividend yield | — | — | — | — | — | 6.51% |
| 1-year change | +84.98% | −35.33% | +75.76% | −21.81% | −47.51% | −41.58% |
| Today | +3.02% | −2.06% | −0.01% | +0.47% | +1.94% | +0.93% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All CPIX news ›Cumberland Pharmaceuticals Wins Fast Track for Ifetroban
Cumberland Pharmaceuticals ( (CPIX) ) has issued an announcement. The most recent analyst rating on (CPIX) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Cumberland Pharmaceuticals stock, see the…
Cumberland Pharmaceuticals Updates Ifetroban DMD Trial Timeline
The latest announcement is out from Cumberland Pharmaceuticals ( (CPIX) ). Spark’s Take on CPIX Stock According to Spark, TipRanks’ AI Analyst, CPIX is a Neutral. Cumberland Pharmaceuticals Inc. is a specialty biopharmaceutical company…
Cumberland Refocuses on Rare Disease Pipeline After Asset Sale
Cumberland Pharmaceuticals ( (CPIX) ) has provided an update. Spark’s Take on CPIX Stock According to Spark, TipRanks’ AI Analyst, CPIX is a Neutral. Cumberland also holds a majority stake in Cumberland Emerging Technologies Inc.,…
Cumberland Pharmaceuticals Inc. (CPIX) Discusses Duchenne Cardiomyopathy NDA Submission and Product Development Strategy - Slideshow
2026-10-28. The following slide deck was published by Cumberland Pharmaceuticals Inc. The following slide deck was published by Cumberland Pharmaceuticals Inc. in conjunction with this event.
Cumberland Pharmaceuticals: The FDA's Phase 3 Question Is Hard To Ignore
Cumberland Pharmaceuticals is now a clinical-stage company focused on ifetroban for DMD cardiomyopathy. Read why CPIX stock is a hold. - Cumberland Pharmaceuticals is now a clinical-stage company focused on ifetroban for DMD…
CUMBERLAND PHARMACEUTICALS ANNOUNCES PLANS TO FILE NEW DRUG APPLICATION FOR IFETROBAN DMD PROGRAM
Cumberland has secured a growing portfolio of patents protecting ifetroban for the DMD heart disease indication. FDA has also conditionally accepted DYSCORBAN® as the proprietary name for the product. More information regarding the FIGHT…
Cumberland announces ifetroban NDA filing plan after shares plummet
Cumberland plans an NDA for ifetroban in Duchenne cardiomyopathy after FDA talks. Read more here - After shares declined almost 49% in Monday's trading session, Cumberland Pharmaceuticals (CPIX) said it will file an NDA for cardiomyopathy…
Cumberland: ifetroban Phase 2a data support safety
Cumberland Pharmaceuticals Inc. (CPIX) is a Tennessee-based specialty pharma company marketing FDA-approved hospital, gastroenterology and oncology products. Cumberland: ifetroban Phase 2a data support safety Cumberland Pharmaceuticals…
Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Results
Ifetroban was well tolerated in patients with systemic sclerosis The majority of subjects in both treatment groups showed limited disease progression during the study, which reduced the ability of a trial of this size to detect a treatment…
Cumberland Pharmaceuticals Announces Special Dividend, Payable on July 31, 2026
Cumberland Pharmaceuticals Inc. announced that its Board of Directors has authorized and declared a special cash dividend of $1.50 per share of the Company's common stock. The dividend will be payable... Cumberland Pharmaceuticals…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- theglobeandmail.com5
- seekingalpha.com3
- marketscreener.com2
- stocktitan.net2
- aol.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.